Biocode Ltd., a subsidiary of Shell Ventures U.K., announcedWednesday that it has been purchased by its management, incollaboration with a consortium of U.K. and U.S. investors, ledby Genzyme Corp.'s founder Henry Blair. Biocode's currentexecutive directors, Tim Wilkinson and Colin Garner, willmanage the new company as managing director and R&Ddirector, respectively. Biocode has developed antibody-basedtechnology that directly identifies counterfeit or adulteratedproducts, traces pollutants and detects contaminants.

(c) 1997 American Health Consultants. All rights reserved.